A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine

Vaccine

Volumn 30, Issue 44, 2012, Pages 6287-6293

  Coleman, Brenda L ^a,b   McGeer, Allison J ^a,b,g   Halperin, Scott A ^c,d,e   Langley, Joanne M ^c,d,e   Shamout, Yassein ^e   Taddio, Anna ^b,f   Shah, Vibhuti ^a,g   McNeil, Shelly A ^c,d,e  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Canadian Center for Vaccinology Dalhousie University Halifax   (Canada)

^d IWK HEALTH CENTRE   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Influenza; Intradermal; Self administration; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG PREFERENCE; DRUG SAFETY; DRUG SELF ADMINISTRATION; FEMALE; GROUPS BY AGE; HEMAGGLUTINATION; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA VACCINATION; INJECTION SITE PAIN; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEASONAL INFLUENZA; SEX DIFFERENCE;

ADOLESCENT; ADULT; DRUG TOXICITY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMAN EXPERIMENTATION; HUMANS; INFLUENZA VACCINES; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; NURSES; QUESTIONNAIRES; SELF ADMINISTRATION; VACCINATION; YOUNG ADULT;

EID: 84865717958     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.006     Document Type: Article

References (24)

1. World Health Organization Influenza (seasonal) 2009, Available from: http://www.who.int/mediacentre/factsheets/fs211/en/ [cited 01.08.10].
2. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(1):36-44.
3. Centers for Disease Control and Prevention Key facts about seasonal flu vaccine 2011, August, Available from: http://www.cdc.gov/flu/protect/keyfacts.htm [cited 02.09.11].
4. Public Health Agency of Canada Canadian immunization guide seventh edition - 2006 2011, Public Health Agency of Canada, Ottawa, ON.
5. National Advisory Committee on Immunization Statement on seasonal trivalent inactivated influenza vaccine (TIV) for 2010-2011. Canada Communicable Disease Report 2010, Public Health Agency of Canada, Ottawa, ON, p. 49.
6. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004, 351(22):2286-2294.
7. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004, 351(22):2295-2301.
8. Arnou R., Eavis P., De Juanes Pardo J.-R., Ambrozaitis A., Kazek M.-P., Weber F. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: randomized, controlled, phase III trial. Hum Vaccin 2010, 6(4):346-354.
9. Ansaldi F., Durando P., Icardi G. Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin Biol Ther 2011, 11(3):415-427.
10. Beran J., Ambrozaitis A., Laiskonis A., Mickuviene N., Bacart P., Calozet Y., et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009, 7(1):13.
11. Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., Karrasch J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008, 198(5):650-658.
12. Jo Y.M. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. J Med Virol 2009, 81(4):722-727.
13. Chiu S.S., Peiris J.S.M., Chan K.H., Wong W.H.S., Lau Y.L. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007, 119(6):1076-1082.
14. Sanofi Pasteur Intanza™ influenza vaccine (split virion, inactivated) product monograph. Toronto, Canada; 2010.
15. Frenck R.W., Belshe R.B., Brady R.C., Winokur P.L., Campbell J.D., Treanor J., et al. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine 2011, 29:5666-5674.
16. Willan AR. Randomize.net. Available from: http://www.randomize.net/.
17. World Health Organization Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season 2010, World Health Organization.
18. Kendal A.P., Pereira M.S., Skehel J.J. Concepts and procedures for laboratory-based influenza surveillance 1982, Centers for Disease Control and Prevention, Atlanta, GA.
19. European Agency for the Evaluation of Medicinal Products Note for guidance on harmonization of requirements for influenza vaccines 1997, European Agency for the Evaluation of Medicinal Products, London, UK.
20. StataCorp Stata/SE for Windows. Version 11.2 2009, StataCorp LP, College Station, TX.
21. Leroux-Roels I., Vets E., Freese R., Seiberling M., Weber F., Salamand C., et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 2008, 26(51):6614-6619.
22. Van Damme P., Oosterhuis-Kafeja F., Van der Wielen M., Almagor Y., Sharon O., Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009, 27(3):454-459.
23. Belshe R.B., Newman F.K., Wilkins K., Graham I.L., Babusis E., Ewell M., et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007, 25(37-38):6755-6763.
24. Müller M.J. Will it hurt less if I believe I can control it? Influence of actual and perceived control on perceived pain intensity in healthy male individuals: a randomized controlled study. J Behav Med 2011, 10.1007/s10865-011-9382-0.